ArticleJACC. Case reports2026
Transjugular Left Atrial Appendage Occlusion in a Patient With Anomalous Inferior Vena Cava.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- When the Highway Is Closed: Transjugular Access and the Expanding Playbook for Left Atrial Appendage Occlusion.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWe report a successful right transjugular Watchman device implantation for left atrial appendage (LAA) occlusion in a patient with anomalous inferior vena cava with azygos continuation, precluding standard transfemoral venous access. KEY STEPS: Ultrasound-guided right internal jugular venous access was obtained and upsized to accommodate the delivery system. Transseptal puncture was performed using an Agilis NxT medium-curve steerable sheath with microcatheter and wire exchanges, followed by staged balloon septal dilatation. The delivery sheath was successfully advanced into the LAA, and the Watchman device was successfully deployed. POTENTIAL PITFALLS: Transjugular LAA occlusion presents unique challenges, including an angulated trajectory, increased risk of carotid injury, technically demanding transseptal puncture, and suboptimal LAA coaxial alignment, necessitating meticulous ultrasound-guided access and continuous transesophageal echocardiographic and fluoroscopic guidance. TAKE-HOME MESSAGES: Transjugular LAA occlusion is feasible but technically demanding. Individualized procedural planning, meticulous imaging guidance, and operator adaptive techniques are critical determinants of procedural success and optimal patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.